English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  The calcium-sensing receptor (CaSR) is a calcium (Ca 2+ ) sensitive G protein-coupled receptor implicated in various biological processes. In particular, it regulates Ca 2+ /Mg 2+ - homeostasis and senses interstitial Ca 2+  levels and thereby controls downstream signalling cascades. Due to its expression in the gut epithelium, the enteric nervous system and smooth muscles and its key function in regulation and coordination of muscular contraction and secretion, it represents an excellent candidate gene to be investigated in the pathophysiology of irritable bowel syndrome (IBS). Disturbed CaSR structure and function may impact gastrointestinal regulation of muscular contraction, neuronal excitation and secretion and consequently contribute to symptoms seen in IBS, such as disordered defecation as well as disturbed gut motility and visceral sensitivity.    Methods  We have therefore genotyped the functional  CASR  SNP rs1801725 in three case control samples from the UK, Belgium and the USA.    Results  Genotype frequencies showed no association in the three genotyped case–control samples, neither with IBS nor with IBS subtypes.    Conclusions  Although we could not associate the SNP to any of the established bowel symptom based IBS subtypes we cannot rule out association to altered Ca 2+  levels and disturbed secretion and gut motility which were unfortunately not assessed in the patients genotyped. This underlines the necessity of a more detailed phenotyping of IBS patients and control individuals in future studies.

No association between the common calcium-sensing receptor polymorphism rs1801725 and irritable bowel syndrome